Armando Christian Perez, also known as global music superstar Pitbull will perform LIVE at AT&T Stadium during halftime of the Dallas Cowboys game on FOX against the Philadelphia Eagles on Thanksgiving Day, Nov. 27, kicking off The Salvation Army’s annual Red Kettle Campaign. The halftime performance marks the 18th year the Dallas Cowboys have partnered with The Salvation Army to launch the campaign, which raises millions of dollars throughout the holiday season. Donations help provide meals and shelter for families, Christmas toys for millions of children, in addition to numerous other social services programs year-round such as substance abuse programs, shelter and counseling for victims of domestic violence, and military veteran assistance.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7346051-pitbull-to-kick-off-salvation-army-red-kettle-campaign-with-halftime-performance-during-dallas-cowboys-thanksgiving-day-game/
Mamma Maria is one of the best and highly renowned restaurants in South Philadelphia area. It is best known for her hand rolled gnocchi and homemade limoncello.
A historic African American Museum in Philadelphia and the only one in the area to offer an extensive collection of slavery artifacts and an array of riveting exhibits and informative presentations.
Philadelphia remodeling is a fully licensed and insured construction services company providing management and general contracting services for all residential and commercial buildings.
An inaugural national research report released today from The Children’s Hospital of Philadelphia (CHOP) and State Farm Insurance Companies® shows that the impact of teen driver crashes extends far beyond teen drivers’ families and friends. In 2008, more than half a million (681,000) people were involved in crashes where a teen driver was behind the wheel. More than 40,000 were injured, and nearly 30 percent of those who died in these crashes were not in cars driven by teens.
To view Multimedia News Release, go to http://www.multivu.com/players/English/47737-Miles-to-Go-Teen-Driver-Safety/
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children’s Hospital of Philadelphia (CHOP) co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/chop/48124/
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Iroko Pharmaceuticals, LLC, a Philadelphia-based pharmaceutical company focused on the development and commercialization of innovative therapeutic products, today announced the opening of its new environmentally friendly corporate headquarters in Philadelphia’s Navy Yard Corporate Center. This milestone is part of the Company’s long-term growth plan as it advances its late-stage pipeline of lower dose submicron non-steroidal anti-inflammatory drugs (NSAIDs) towards commercialization.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58559-iroko-pharmaceuticals-opens-philadelphia-headquarters-hq
Two beautiful baby girls had their public debut today at The Children’s Hospital of Philadelphia: Allison June and Amelia Lee Tucker, formerly conjoined twins, separated at the Hospital on Nov. 7. The Hospital held a press conference this morning to highlight this new phase in the lives of both infants.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59552-children-s-hospital-of-philadelphia-tucker-conjoined-twins-separated
Eighteen years after opening its internationally prominent Center for Fetal Diagnosis and Treatment, The Children’s Hospital of Philadelphia (CHOP) celebrates 1,000 fetal surgeries – highly complex surgical interventions to repair birth defects in the womb. Approximately 4,000 fetal surgeries have been done worldwide, meaning a quarter of them have been performed at CHOP, the largest number of any hospital in the world.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62038-children-s-hospital-of-philadelphia-celebrates-1000-fetal-surgeries
The Children’s Hospital of Philadelphia today announced the largest charitable donation in its history: a landmark $50 million gift from the Buerger family toward the construction of a new state-of-the-art outpatient facility. Currently under construction on the Hospital’s Main Campus in West Philadelphia, the building will be named the Buerger Center for Advanced Pediatric Care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62177-children-s-hospital-of-philadelphia-buerger-center-advanced-pediatric-care
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
